2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Risk Behavior: new trials by email Literature Review of Risk Behavior trials Research Report on Risk Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men Emtricitabine / Tenofovir Disoproxil Oral Tablet, DOT Diary mobile app - Adherence, Medication, Risk Behavior | Phase 4 | Completed | Public Health Foundation Enterprises, Inc. | 100 | 2019-02-01 | 2025-07-03 |
| DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence Emtricitabine / Tenofovir Disoproxil Oral Tablet, DOT Diary mobile app - Adherence, Medication, Risk Behavior | Phase 4 | Completed | Public Health Foundation Enterprises, Inc. | 20 | 2018-02-28 | 2021-10-27 |
Medication Adherence (2) · Risk-Taking (2)
Behavior (2) · Health Behavior (2) · Patient Acceptance of Health Care (2) · Patient Compliance (2) · Treatment Adherence and Compliance (2)
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2)
Public Health Foundation Enterprises, Inc. (2)
United States (2)
R01MH109320 (2)